Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22^nd Annual Global Healthcare Conference on Wednesday, September 4^th, held at the New York Marriott Marquis, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice President, Innovative Medicine, R&D will represent the Company in a session scheduled at 10:45 am (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/

Media contact:

media-relations@its.jnj.com



Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson